Results 141 to 150 of about 3,418,065 (230)

Differences in the aggressiveness of familial versus sporadic non-medullary thyroid cancer: An unresolved controversy. [PDF]

Arch Endocrinol Metab
Miasaki FY, Cavalcanti TCS, Graf H, Kimura ET, Kopp PA, Carvalho GA.   +5 more
europepmc   +1 more source

Medullary thyroid cancer, papillary thyroid microcarcinoma and Graves' disease: an unusual clinical coexistence.

, 2001
We describe the unusual case of a Caucasian woman who had a diagnosis of medullary thyroid cancer and papillary microcarcinoma 5 years after a diagnosis of Graves' disease. The patient came to our observation for recurrence of hyperthyroidism.
Carella C., FRANCO, Renato, Amato G, Manganella G, RAMBALDI, Pier Francesco, Mazziotti G, Capone S, Colantuoni V, Rotondi M   +8 more
core  

Long-term outcomes in medullary thyroid cancer patients treated with [¹⁷⁷Lu]Lu-DOTAGA.FAPi dimer therapy. [PDF]

EJNMMI Res
Ballal S, Priyanka GB, Yadav MP, Chandekar KR, Roesch F, Sakir M, Agarwal S, Bal C.   +7 more
europepmc   +1 more source

Medullary thyroid carcinoma: The third mostcommon thyroid cancer reviewed

, 2011
Medullary thyroid cancer is a type of thyroid cancer of neuroendocrine origin. It occurs in hereditary and sporadic forms, and its aggressive behavior is associated with the clinical presentation and type of RET mutation.
Kontzoglou, K., Lazaris, A., Safioleas, K., Stefanaki, C., Katsaronis, P., Stamatakos, M., Paraskeva, P.   +6 more
core  

Long-term calcitonin after thyroidectomy for medullary thyroid cancer in MEN2A. [PDF]

Endocr Relat Cancer
van den Berg ML, van Beek DJ, van den Broek MFM, Lodewijk L, Verrijn Stuart AA, Terwisscha van Scheltinga SCEJ, van Leeuwaarde RS, Borel Rinkes IHM, Vriens MR.   +8 more
europepmc   +1 more source

Data Harmonization for Collaborative Research Among Australian and US Registries: A Case Study in Medullary Thyroid Cancer (MTC). [PDF]

World J Surg
Moore EC, Serpell J, Ruseckaite R, Ioannou L, Bauzon J, Romero-Velez G, Shin J, Siperstein A, Papachristos A, Sidhu S, Sywak M, Ahern S, Pourghaderi A.   +12 more
europepmc   +1 more source

Selpercatinib versus multi-kinase inhibitors for advanced medullary thyroid cancer: A network meta-analysis of RET-targeted therapies. [PDF]

Front Endocrinol (Lausanne)
Wang J, Cao G, Liu Y, Qiao H, He Q, Zheng B.   +5 more
europepmc   +1 more source

Comparison of ⁶⁸Ga-FAPI and ¹⁸F-DOPA PET/CT in patients with medullary thyroid cancer. [PDF]

Front Endocrinol (Lausanne)
Hescheler DA, Atiyat D, Lorenz K, Heinzel A, Reschke P, Almaguel FG, Petersen M, Eppard E, Wybranska J, Wuestemann J, Kreissl MC.   +10 more
europepmc   +1 more source

A prospective, exploratory study of ¹⁸F-PSMA-1007 PET/CT in patients with medullary thyroid cancer. [PDF]

Eur J Nucl Med Mol Imaging
Jager EC, Kruijff S, Kloet RW, Links TP, Brouwers AH.   +4 more
europepmc   +1 more source

MYELOstudy: lymph node stage of aggressiveness in medullary thyroid cancer-a retrospective multi-center study analysis. [PDF]

Updates Surg
Papavramidis T, Chorti A, Bakkar S, Raffaelli M, Košec A, Hoang VT, Lim JY, Genc V, Minuto MN, Calò PG, Hellmann A, Di Filippo G, Karakozis L, Chrisoulidou A, Gamgaram VKD, Sriphrapradang C, Leclère JC, Orois A, Marco D, Dhiwakar M, de Pasquale L, Buemi A, Nesti C, Pandev R, Chala A, Yalıman SS, Hajiioannou J, Liu SY, Cherenko S, Voloudakis N, Koutelidakis I, Nastos K, Constanza R, Dobrinja C, Brunner M, Bains L, Panchangam RB, Girardi FM, Arikan AE, El Malki HO, de Cillia M, Oragano L, Pliakos I, Moysidis M, Pennestrì F, De Crea C, Čukman M, Tarle A, Senashova OS, Shindo ML, Tüzken İ, Turhan MA, Varaldo E, Albertelli M, Medas F, Canu GL, Cappellacci F, Śledziński M, Lazzari G, Morelli E, Karakozis S, Boudina M, Katsamakas M, Guevara MI, Aroonroch R, Manyalich M, Vidal O, Triponez F, Masse N, Kathirvel L, Muthusamy R, La Rubia P, Castellani L, Maria-Cristina B, Raluca-Maria F, Kaderli R, Teksoz S, Chow TC, Lai MS, Shchekaturova L, Bellou E, Banus M, Da Milano R, Mastronardi M, Grützmann R, Hauth LA, Abentroth AL, Dulgeroglu O, Uras C, Placentino G, Leutner M.   +90 more
europepmc   +1 more source